Event on 2012-08-26 19:00:00
Summer Lovin' 2012
What is TEEN LINE? TEEN LINE is a confidential telephone helpline for teenaged callers. It operates every evening from 6:00pm to 10:00pm PST and is toll-free from anywhere in California. If you have a problem or just want to talk with another teen who understands, then this is the right place for you! You can call us at 310-855-HOPE(4673) and even text us by texting “TEEN” to 839863. TEEN LINE also offers message boards, resources and information. The TEEN LINE volunteers who answer the calls, emails and chats are Southern California teenagers who have been specially trained. They won’t judge you or give advice – their job is to listen to your feelings and help you to clarify your concerns, define the options available to you, and help you make positive decisions. No problem is too small, too large, or too shocking for the TEEN LINE volunteers. PROBLEMS SOME TEENAGERS FACE … Abuse, AIDS, alcoholism, depression, divorce, drugs, gangs, homelessness, pregnancy, sexuality, violence, suicide. SOME FACTS ABOUT TEEN LINE … The hotline receives almost 10,000 calls each year More than 35,000 attend our outreaches to schools & community groups Our website receives more than 140,000 visitors from all over the world We have provided Suicide Prevention Training to the Los Angeles Police Department’s Juvenile Procedures School since 1996 Certified by the American Association of Suicidology (1-800-SUICIDE) TEEN LINE is unique … Our Teen Listeners have a special ability to understand and empathize with callers because they are teens themselves … they speak their language. Resource Associates, all mental health professionals, volunteer their time each night to provide on-site supervision and support to the Teen Listeners, especially important after a particularly traumatic call. Our Community Outreach Program reaches over 30,000 each year, opening dialogues and educating the community about issues pertinent to adolescence. Our Teen Suicide Prevention Training has been a regular part of the Los Angeles Police Department’s Juvenile Procedures School curriculum since 1996. TEENLINE History … TEEN LINE was created in 1980 by a group of mental health professionals who, through their personal work with teenagers, realized that a more inclusive approach to adolescent mental health was needed. After extensive research and consultation, TEEN LINE – a teen-to-teen hotline with community outreach services – was born. TEEN LINE has been an affiliated program of the Cedars-Sinai Medical Center’s Department of Psychiatry since its inception. TEEN LINE is based on the premise that when teenagers encounter problems, they usually turn first to their peers for advice. Many teens think their parents can’t possibly understand what’s happening in their lives and that their friends might laugh or abandon them. TEEN LINE provides a safe, confidential place to talk things out with another teen who can understand and will listen, but not judge. This simple act of listening can make a huge difference – sometimes a life-saving one. Each year nearly 9,000 young people call the hotline and more than 30,000 attend our outreaches. Teens know they can trust TEEN LINE – and they do.
at Troubadour
9081 Santa Monica Boulevard
West Hollywood, United States
2nd Annual Clinical Trials Asia Summit 2011 Conference “A critical guide for successfully conducting clinical trials” May 13th 2011, ITC Maratha, Mumbai, India
Event on 2012-08-13 08:30:00
Key Themes Discussed at this Summit:
• Where does India stand in the current global clinical trials market and how to take advantage of the same? How can you take advantage of the global market for clinical trials?
• Discovering technologies and strategies for successful clinical trial management
• Strategies in conducting successful interventional oncology trials in India
• Setting up clinical trial research hub & techniques for applying risk management principles.
• Discovering global opportunities in clinical trial and selecting the right partners to penetrate successfully into the Indian market
• Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India to develop appropriate clinical studies
• Avoiding potential pitfalls of trials agreement
• Regulatory review at the Drugs Controller General of India (DCGI) and Central
Drugs Standard Control Organization (CDSCO): science, quality, and speed
• Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
• Effectively managing cold chain and logistics in clinical trials
• Optimising clinical trials operation effectiveness and ROI through strategic site,patient, data and risk management in the regulated markets
• What are the issues with off-shoring trials to countries such as India & South Asia? – Solutions?
• Motivating and managing clinical project teams to improve timeline and progress
• Exploring the efficacy and safety of new interventions in clinical trials
• Drawing and retaining clinical talent pool to minimise turnover in clinical studies
• Next generation of clinical trials – How big will the market be?
Key Speakers :
• Arun Bhatt, President, Clininvent Research
• Bhaswat S. Chakraborty, Senior Vice President, Research and Development, Cadila
• Girish S. Gudi, Vice President, Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals
• Ammar Raza, Associate Director- Medical Affairs, AstraZeneca
• Viraj Rajadhyaksha, Associate Director - Medical Liaison, Sanofi-Aventis
• Arani Chatterjee, Vice President, Clinical Research, Panacea Biotec
• Rohit Arora, Deputy Director, Sanofi Pasteur
• Prashant Bodhe, Head Regulatory Affairs & Vice President Operations, DMRI
• Subashri Shivkumar, Hub Unit Director-Regional Clinical Operations, Bristol-Myers Squibb
• Chirag Trivedi, Head - Medical Affaris Clinical Operations, Sanofi-Aventis
• Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
• Farzana Lakdavala, Medical Advisor, Project Manager Clinical Research, Wockhardt
• Murtuza S. Bughediwala, General Manager, Clinical Operations & Business Development, Clininvent Research
• Poonam Sule, Senior Manager - Clinical Research (International), Wockhardt
• Ashish Gawde, Senior Manager- Clinical Research, BAYER
• Jeroze Dalal, General Manager Clinical Operations, GlaxoSmithKline
Plus many more
Who Should Attend:
Vice Presidents, Directors Heads & Managers of:
• Clinical Research & Development
• Clinical Research Services
• Clinical Operations
• Clinical Data Management
• Clinical IT
• Clinical Trials
• Medical Affairs
• Regulatory Affairs
• Compliance
• Quality control / Assurance/GCP
• Clinical Study Design
• Safety Surveillance
• Subject Recruitment
• E-Clinical Systems
Target Audience – Industry:
• Pharmaceutical Organisations
• Generic pharmaceutical companies
• Contract Research Organisations
• Patient Recruitment Companies
• Government- Department of Health
• Non-profit organisations/ Association
• Academics
• Consultants
Why Should You Attend?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Ordering Delegate Pass – Register Now
Ordering is simple! You can simply email or call and book your seats on
TEL: +91 (44) 23770517 . Email – delegate@virtueinsight.com
For this one day conference, conference fee is 05,000 INR + tax per person
Should you have any queries, please feel free to write to us pradeep@virtueinsight.com, pradeepvic@yahoo.com
at Grand Intercontinental
Mumbai
Mumbai, India
Richardson Cancer Diet By Dr. Janet Hull
A Natural Effective Cancer Diet For People With Cancer Or For The Prevention Of Cancer.
Sarcoidosis Remission - Aden Protocol
At Last People Can Stop The Terrible Suffering Of Sarcoidosis. Modern Medicine Is Powerless With This Disease. The Aden Protocol Resource Book Is A Guide To The Only Natural Alternative That Is Proven To Work.
No comments:
Post a Comment